Marcello Maugeri-Saccà

8PUBLICATIONS
98CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.

|Jul 14, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

|May 25, 2026
Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|Jul 09, 2024
Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy.

Stefano Scalera, Biagio Ricciuti, Daniele Marinelli

|Dec 30, 2020
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer.

Frauke Goeman, Francesca De Nicola, Carla Azzurra Amoreo

Pageof 2

Frequent Collaborators

5 joint publications

Stefano Scalera

5 joint publications

Biagio Ricciuti

4 joint publications

Laura Cipriani

4 joint publications

Alessandro Di Federico